Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Of Candida albicans strains

L. Millon, A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and Y. Michel-Briand, Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients persistence of Candida albicans strains with the same genotype,. Clin. Microbiol., 32, 1115, 1994. [Pg.116]

Borg-von Zepelin M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A, Monod M HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 1999 13 747-751. [Pg.127]

Yucesoy, M. Esen, N. Yulug, N. Use of chromogenic tube and methyl blue-sabouraud agar for the identification of Candida albicans strains. Kobe J. Med. Sci. 2001, 47, 161-167. [Pg.25]

Perea S, JL Lopez-Ribot, WR Kirkpatrick, RK McAtee, RA Santillan, M Martinez, D Calabrese, D Sanglard, TP Patterson (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antibicrob Agents Chemother 45 2676-2684. [Pg.179]

Shibata, N., Kobayashi, H., Tojo, M. and Suzuki, S. (1986) Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-IOOT. Archives of Biochemistry and Biophysics, 251 (2), 697-708. [Pg.55]

Standard and the isolated strains of the following bacteria, namely Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 10145), Proteus mirabilis (ATCC 7002), Klebsiella pneumoniae (RSKK 574), Acinetobacter baumannii (RSKK 02026), Staphylococcus aureus (ATCC 25923), and Enterococcus faecalis (ATCC 29212) for determination of antibacterial activity, along with standard strains of Candida albicans (ATCC 10231) and C. parapsilosis (ATCC 22019) were used for determination of antifungal activity. [Pg.99]

Y. Kondoh, K. Shimizu, and K. Tanaka, Proteinase production and pathogenecity of Candida albicans II. Virulence for mice of C. albicans strains of different proteinase activity, Microbial. Immuno., 31, 1061, 1987. [Pg.116]

Donovan M, Schumuke JJ, Fonzi WA, Bonar SL, Gheesling-Mullis K, Jakob GS, Davisson VJ, Dotson SB Virulence of a phosphoribosylaminoimidazole carboxylase-deficient Candida albicans strain in an iimnimosuppressed murine model of systemic candidiasis. Infect Immun 2001 69 2542-2548. [Pg.124]

Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, Becker JM Altered expression of selectable marker URA3 in gene-dismpted Candida albicans strains complicates interpretation of vimlence studies. Infect Iimnim 1998 66 5301-5306. [Pg.124]

Ray TL, Payne CD, Soil DR Variable expression of Candida acid proteinase by switch phenotypes of individual Candida albicans strains. Clin Res 1988 36 687. [Pg.125]

Calderone RA, Wadsworth E Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avimlent strain. Rev Infect Dis 1988 10 S423-S427. [Pg.125]

Trovato et al. [49] reported the antimycotic activity of aqueous, ethanol and petroleum ether extracts of Matricaria recutita L. These extracts inhibited in vitro strains of Candida albicans isolated from clinical samples obtained in the course of acute vaginitis. [Pg.452]

Saccharomyces cerevisiae i i27-8b strain. The latter compound also inhibited the growth of Candida albicans 258 strains. [Pg.902]

Kakeya, H., Y. Miyazaki, H. Miyazaki, K. Nyswaner, B. Grimberg, and J.E. Bennett (2000). Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob. Agents Chemother. 44, 2985-2990. [Pg.616]

Franz, R., M. Ruhnke, D.C. Lamb, S.L. Kelly, and J. Morschhauser (1998). Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42, 3065-3072. [Pg.618]

C. LassFlorl, and E. Einsele (1997). Molecular analysis of CYP51 from fluconazole-resistant Candida albicans strains. FEMS Lett. 151, 263-268. [Pg.618]

The mannans isolated from Candida albicans strains, NIH A-207 (serotype A), NIH B-792 (serotype B), and J-1012 (serotype C), were fractionated on a column of DEAE-Sephadex into five subfractions containing different amounts of phosphate. [Pg.110]

LJ Schep, DS Jones, MG Shepherd. Primary interactions of three quaternary ammonium compounds with blastospores of Candida albicans (MEN strain). Pharm Res 12(5) 649-652, 1995. [Pg.116]

Polyene Resistance - Two of 51 in vitro induced nystatin resistant strains of Cryptococcus neoformans showed cross resistance to amphotericin B.l >121 Studies using three in vitro induced nystatin resistant mutants of Saccharomyces cerevisiae indicated that cross resistance correlated with polyene size.122 variants of Candida albicans resistant to... [Pg.144]

See other pages where Of Candida albicans strains is mentioned: [Pg.215]    [Pg.343]    [Pg.142]    [Pg.95]    [Pg.508]    [Pg.326]    [Pg.340]    [Pg.118]    [Pg.83]    [Pg.787]    [Pg.460]    [Pg.450]    [Pg.204]    [Pg.833]    [Pg.114]    [Pg.364]    [Pg.86]    [Pg.94]    [Pg.86]    [Pg.212]    [Pg.166]    [Pg.505]    [Pg.87]    [Pg.280]    [Pg.311]   


SEARCH



Albicans

Candida

Candida albicans

Candida albicans strain

© 2024 chempedia.info